Holen Sie sich die Stockscreener-App
136.67
0.51%
-0.70
Handel nachbörslich:
136.67
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Illumina Inc Aktie (ILMN) Neueste Nachrichten
Genetic Testing Market Projected To Witness Substantial Growth, 2025-2032: Eurofins Scientific, Illumina Inc., - EIN News
Cancer Biopsy Market Size is Expected to Reach USD 60.92 Billion by 2033, Growing at a CAGR of 7.81%: Straits Research - GlobeNewswire Inc.
Illumina, Inc.'s (NASDAQ:ILMN) Price Is Out Of Tune With Revenues - Simply Wall St
Illumina, Inc. (NASDAQ:ILMN) Receives $165.63 Average PT from Analysts - MarketBeat
Microfluidics Market Poised for Substantial Growth (2025-2032) | PerkinElmer, Agilent Technologies, Inc., Illumina. - openPR
Key Trends in the Bioinformatics Market with Insights from - openPR
Sax Wealth Advisors LLC Invests $561,000 in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Avanza Fonder AB Buys Shares of 17,599 Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina Partners NVIDIA for Genomic Advancements, ILMN Stock Climbs - MSN
JP Morgan 2025: analysts remain doubtful of Illumina’s growth - MSN
Gateway Investment Advisers LLC Raises Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Video: The first NovaSeq X in the Benelux region is a “game changer” - Illumina
Bioinformatics Market Analysis, Size, Share, and Growth - openPR
Illumina, Inc. (NASDAQ:ILMN) Shares Sold by Sicart Associates LLC - MarketBeat
Whole Exome Sequencing Market Overall Study Report 2025-2032 | - openPR
Global Single Cell Bioinformatics Software and Service Market - openPR
Why Illumina (ILMN) is Poised to Beat Earnings Estimates Again - Yahoo Finance
Beech Hill Advisors Inc. Boosts Stake in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina, Inc. (NASDAQ:ILMN) Short Interest Update - MarketBeat
USA Financial Formulas Acquires New Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Lab-on-a-chip and Microarrays (Biochip) Market Future - openPR
Biomarker Research Services Market Projected To Witness Substantial Growth, 2025-2032:Abbott Laboratories, - EIN News
Illumina (NASDAQ:ILMN) Trading Up 5.7%Time to Buy? - MarketBeat
Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2024 and Provides Preliminary Outlook for Fiscal Year 2025 - Longview News-Journal
Illumina, Inc. (NASDAQ:ILMN) Shares Acquired by CCLA Investment Management - MarketBeat
Illumina, Nvidia Launch AI-Based Genomics Partnership - Genetic Engineering & Biotechnology News
Future-Proofing Growth of DNA Data Storage Market, Size, - openPR
Molecular Diagnostics Market Size, Share & Business Opportunities forecast by 2031 | F. Hoffmann-La Roche Ltd, - EIN News
RNA Sequencing Market 2024-2031 Global Industry Analysis, - openPR
Illumina CEO Highlights Genomics Future and Nvidia Partnership at JPMorgan Health-Care Conference - HPBL
Genomic Cancer Testing Market Future Business Opportunities - openPR
Illumina partners with Nvidia on AI-powered genomic sequencing - MSN
Illumina reports preliminary Q4 results, provides 2025 expectations - MSN
Illumina CEO Thaysen on Nvidia Partnership, Genomics, M&A - Marketscreener.com
Nvidia Announces Partnerships with Mayo Clinic, Illumina & More at JPM25 - Dealbreaker
Illumina Raises Q4 Revenue Outlook To $1.10 Billion, Exceeding Street Expectations; Sees Solid Margins - Benzinga
Illumina (NASDAQ:ILMN) Issues FY 2024 Earnings Guidance - MarketBeat
Illumina posts modest Q4 revenue growth, anticipates 2025 rise - Investing.com
Illumina (NASDAQ:ILMN) Issues Q4 Earnings Guidance - MarketBeat
Illumina stock falls on 2025 outlook miss By Investing.com - Investing.com Australia
Illumina, Nvidia collaborate to decode biology and propel precision health - Yahoo Finance
Illumina stock falls on 2025 outlook miss - Investing.com
Truveta sells stakes to Regeneron, Illumina in deal to build genetic database - MSN
Nvidia (NVDA) Expands Healthcare Presence with Illumina Partnership - TipRanks
Illumina (NASDAQ:ILMN) Trading 5.7% HigherWhat's Next? - MarketBeat
Illumina partners with NVIDIA for advanced genomics analysis By Investing.com - Investing.com Canada
Morgan Stanley Cuts Illumina (NASDAQ:ILMN) Price Target to $150.00 - MarketBeat
Illumina, Nvidia team to use AI in foundation models - MedTech Dive
Illumina and Regeneron invest $139.5m in Truveta to build largest genetic database - Yahoo Finance
Illumina and NVIDIA Just Dropped a Genomics Bombshell - GuruFocus.com
Nvidia partners with Illumina, IQVIA use generative AI to boost drug discovery (NVDA:NASDAQ) - Seeking Alpha
Nvidia Partners With Illumina and Mayo Clinic in Health Push - Bloomberg
NVIDIA (NVDA) Expands AI Reach into Healthcare with Illumina Par - GuruFocus.com
Illumina partners with NVIDIA for advanced genomics analysis - Investing.com
Illumina and NVIDIA collaborate to decode biology and propel precision health - PR Newswire
Regeneron, Illumina join $320m Truveta investment - pharmaphorum
JP Morgan 2025: NVIDIA partners with IQVIA, Illumina and Mayo Clinic - Yahoo Finance
Truveta, Regeneron, and Illumina Join Forces for Unprecedented Genetic DatabaseNews and Statistics - IndexBox, Inc.
Illumina launches pilot proteomics program with UK Biobank and biopharma collaborators to analyze 50,000 samples - WV News
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):